NEW YORK (GenomeWeb News) - The City of Hope National Medical Center has purchased Sequenom's MassArray genetic analysis system and portfolio of application tools, Sequenom said today.
City of Hope will use MassArray for its molecular marker research and individualized cancer care initiatives, the company said.
Garry Larson, an associate research scientist at City of Hope, said in a statement that the center will use Sequenom's platform for quantitative gene expression and methylation studies.
Larson added that the center will use the genotyping system "as an integral part of our ongoing research both to identify individuals at high risk for developing cancer, and to aid in the development of therapeutic modalities based on the unique genetic profile of a given patient."
Financial details of the purchase were not disclosed.